Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Jamaica
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lichtenstein
  Lithuania
  Luxembourg
  Madagascar
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Mozambique
  Namibia
  Netherlands
  New Zealand
  Nigeria
  Norway
  Panama
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Uganda
  Ukraine
  United Kingdom
  United States
  Vietnam


   All

Last Update: 21-01-2014  
Related category(ies):
Health & life sciences  |  Success stories

 

Countries involved in the project described in the article:
Belgium  |  Finland  |  Germany  |  Netherlands  |  Switzerland
Add to PDF "basket"

The secret life of insulin-producing cells

The insulin-producing cells in the pancreas play a crucial role in the management of our blood sugar levels. If they don’t work properly, the body can no longer cope with glucose.
New imaging techniques developed through EU support are enabling researchers to take a closer look at the birth, life and death of these precious cells in their quest to improve the prevention and management of diabetes.

© Radboudumc 2013

According to the World Health Organization (WHO), 347 million people worldwide are living with diabetes, and this figure is growing fast. Unless it is treated effectively, this chronic disease can cause complications that severely impair patients’ quality of life.

It also affects their life expectancy. By 2030, the WHO expects diabetes to be the world’s seventh leading cause of death.

There are two main types of diabetes. Type 2 diabetes is frequently preventable, and it is usually possible to avoid or delay the appearance of symptoms. Type 1 diabetes is an autoimmune disease whose origins remain puzzling. New insights that would help to refine prevention and management, applicable to any type of diabetes, could further improve the prospects, enabling more of us to stay healthier longer.

The EU-funded project BetaImage set out in 2008 to take diabetes research and treatment a step further. The project’s team has developed new imaging techniques that allow researchers to find out more about beta cells, the pancreatic cells that produce insulin.

The many faces of diabetes

Insulin enables the body to absorb glucose from the bloodstream. If the body does not produce enough of it, blood sugar can rise to harmful levels. This lack or loss of beta cell function is a main cause of diabetes. Other cases are due to a physiological inability to process insulin, although in fact both factors often combine.

Beta cells are located in parts of the pancreas referred to as the ‘islets of Langerhans’. They are destroyed as the disease progresses. How this correlates with the disease’s progression is currently unclear.
It is also not necessarily clear if a specific case is caused by loss of function or by insulin resistance, as diabetes is usually diagnosed using tests that cannot distinguish between the two.

“Losing beta cells is something that happens in every patient in the long run,” says Prof. Martin Gotthardt of Radboud University Medical Centre in the Netherlands, BetaImage’s project coordinator. “But the patients may be at completely different stages of the disease when they are diagnosed. This may have implications for the treatment, and right now, we don’t adapt our treatment to that.”

A clearer image of pancreatic function

A safe, non-invasive way to check the state of patients’ beta cells could help to make treatments more effective, and the BetaImage team was determined to provide it. As one of several promising outcomes, the team has identified targets specific to these beta cells and developed radioactive tracer molecules that bind to them, making the cells visible for imaging equipment that detects this radiation.

Prof. Gotthardt is quick to point out that this technique has only just entered clinical trials and will not be widely available for several years. He adds that the initial results are encouraging and that the possibilities extend well beyond establishing beta cell mass.

Different tracers can potentially be used to assess different aspects – for example, if the beta cells are active, or if they are under attack from the immune system.

Another technology developed by the project will allow scientists to keep tabs on actual living islets. It takes existing optical coherence tomography to new heights by achieving near-cellular resolution.

The enhanced technique is known as optical coherence microscopy. It cannot be used to examine the pancreases of diabetes patients as it cannot ‘look’ far enough into the body (it is based on light, which cannot penetrate far beyond the surface of biological tissue). It does, however, offer unprecedented possibilities for diabetes research, where it can for example be used to observe the isolated pancreases of test animals.

“You can actually see differences between islets in a three-dimensional manner in a living pancreas, which until now in a living animal was not possible,” says Prof. Gotthardt.

The project ended in March 2013. Its results are feeding into a new project, BetaTrain, which is cross-validating new imaging technologies for use in diabetes imaging centres across Europe.

  • Project acronym: Betaimage
  • Participants: Netherlands (Coordinator),Switzerland,Germany,Belgium, Finland
  • FP7 Proj. N° 222980
  • Total costs: € 7 086 487
  • EU contribution: € 5 447 136
  • Duration: October 2008 to March 2013

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center